within Pharmacolibrary.Drugs.ATC.N;

model N05BA16
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 0.012833333333333334,
    adminDuration  = 600,
    adminMass      = 0.01,
    adminCount     = 1,
    Vd             = 0.0635,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005833333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Nordazepam (desmethyldiazepam) is a benzodiazepine derivative acting as an anxiolytic and sedative. It is a metabolite of diazepam, chlordiazepoxide, and others. While not widely prescribed as a standalone drug today, it is still detected in patients as a result of metabolism of other benzodiazepines. It is not typically approved for standalone use in many countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li>Le-le Wang, Xin-Xin Ren, Yi He, Guan-Feng Cui, Zhi-Wen Wei, Juan Jia, Jie Cao, Yao Liu, Bin Cong, Yong Niu, Ke-Ming Yun,Study on the Pharmacokinetics of Diazepam and Its Metabolites in Blood of Chinese People.,European journal of drug metabolism and pharmacokinetics,2020<a href='https://pubmed.ncbi.nlm.nih.gov/32219697/'>https://pubmed.ncbi.nlm.nih.gov/32219697/</a></li><li>Le-le Wang, Xin-Xin Ren, Yi He, Guan-Feng Cui, Zhi-Wen Wei, Ke-Ming Yun,An Experimental Pharmacokinetics Study of Diazepam and Its Metabolites in Oral Fluid of Chinese Population.,Journal of analytical toxicology,2020<a href='https://pubmed.ncbi.nlm.nih.gov/31965188/'>https://pubmed.ncbi.nlm.nih.gov/31965188/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N05BA16;
